Changes to the Code
H.R. 8447 · Protecting America from Seasonal and Pandemic Influenza Act of 2026 · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
2 U.S.C. § 901 Enforcing discretionary spending limits
1 change the bill asks for here, 1 carried out
- Carried out:
Section 251(b)(2) of the Balanced Budget and Emergency Deficit Control Act of 1985 (2 U.S.C. 901(b)(2)) is amended by adding at the end the following:
(H) Health defense operations.— (i) If, for any fiscal year, appropriations for discretionary accounts are enacted that the Congress designates in statute on an account-by-account basis as being for health defense operations, then the adjustment for that fiscal year shall be the …
§ 901(b)–(c)
Start of § 901 to (b)(2)(F)(ii)(II)(bb) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (b)(2)(F)(ii)(II)(cc) | (cc) | (cc) | ||
| the funds necessary to repay any transfers needed for the costs of wildfire suppression operations. | the funds necessary to repay any transfers needed for the costs of wildfire suppression operations. | |||
| (b)(2)(G) | (G) The 2020 Census | (G) The 2020 Census | ||
| If, for fiscal year 2020, appropriations for the Periodic Censuses and Programs account of the Bureau of the Census of the Department of Commerce are enacted that the Congress designates in statute as being for the 2020 Census, then the adjustment for that fiscal year shall be the total of such appropriations for that fiscal year designated as being for the 2020 Census, but shall not exceed $2,500,000,000. | If, for fiscal year 2020, appropriations for the Periodic Censuses and Programs account of the Bureau of the Census of the Department of Commerce are enacted that the Congress designates in statute as being for the 2020 Census, then the adjustment for that fiscal year shall be the total of such appropriations for that fiscal year designated as being for the 2020 Census, but shall not exceed $2,500,000,000. | |||
| (b)(2)(H) | (H) [inserted: Health defense operations.—] | |||
| (b)(2)(H)(i) | (i) [inserted: ] | |||
| [inserted: If, for any fiscal year, appropriations for discretionary accounts are enacted that the Congress designates in statute on an account-by-account basis as being for health defense operations, then the adjustment for that fiscal year shall be the total of such appropriations for that fiscal year.] | ||||
| (b)(2)(H)(ii) | (ii) [inserted: ] | |||
| [inserted: Any report or explanatory statement accompanying an appropriations Act that contains an account with amounts that are designated as being for health defense operations pursuant to clause (i) shall specify each program, project, or activity that will be funded by such amounts, and a specific dollar amount provided for each such program, project, or activity.] | ||||
| (c) | (c) Discretionary spending limit | (c) Discretionary spending limit | ||
| As used in this subchapter, the term “discretionary spending limit” means— | As used in this subchapter, the term “discretionary spending limit” means— | |||
| (c)(1) | (1) | (1) | ||
| for fiscal year 2014— | for fiscal year 2014— | |||
Rest of § 901 unchanged
42 U.S.C. § 247d–7e Biomedical Advanced Research and Development Authority
5 changes the bill asks for here, 3 carried out
- Carried out:
in subparagraph (C), by striking
and
at the end; - Carried out:
in subparagraph (D), by striking the period at the end and inserting
; and
; and - Not carried out:
by adding at the end of the following:
(E) supporting pandemic influenza countermeasure preparedness.; and
We can't read how this instruction is worded yet, so it isn't shown in the text.
Technical detail
no-pattern: adding at the end of the following: QCONTENT; and - Not carried out:
in paragraph (4), by adding at the end of the following:
(H) Pandemic influenza medical countermeasures program.— In carrying out paragraph (2)(E), the Secretary shall establish and implement a program that— (i) supports research and development activities for qualified pandemic or epidemic products (as defined in section 319F–3), …
We can't read how this instruction is worded yet, so it isn't shown in the text.
Technical detail
no-pattern: adding at the end of the following: QCONTENT. - Carried out:
Section 319L(d) of the Public Health Service Act (42 U.S.C. 247d–7e(d)) is amended by adding at the end the following:
(3) Pandemic influenza.— To carry out this section and section 2811 with respect to pandemic influenza, in addition to amounts authorized to be appropriated by paragraph (2) and any amounts authorized to be appropriated by section 2811, there is authorized to be appropriated …
§ 247d–7e(c)Biomedical Advanced Research and Development Authority(2)–(4)
Start of § 247d–7e to (c)(2)(A) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (2)(B) | (B) | (B) | ||
| promoting countermeasure and product advanced research and development, including through the establishment and maintenance of domestic manufacturing surge capacity and capabilities, consistent with subsection (a)(6)(B)(iv); | promoting countermeasure and product advanced research and development, including through the establishment and maintenance of domestic manufacturing surge capacity and capabilities, consistent with subsection (a)(6)(B)(iv); | |||
| (2)(C) | (C) | (C) | ||
| facilitating contacts between interested persons and the offices or employees authorized by the Secretary to advise such persons regarding requirements under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.] and under section 262 of this title; | facilitating contacts between interested persons and the offices or employees authorized by the Secretary to advise such persons regarding requirements under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.] and under section 262 of this title; | |||
| (2)(D) | (D) | (D) | ||
| promoting innovation to reduce the time and cost of countermeasure and product advanced research and development | promoting innovation to reduce the time and cost of countermeasure and product advanced research and development[inserted: ; and] | |||
| (3) | (3) Director | (3) Director | ||
| The BARDA shall be headed by a Director (referred to in this section as the “Director”) who shall be appointed by the Secretary and to whom the Secretary shall delegate such functions and authorities as necessary to implement this section, including the execution of procurement contracts, grants, and cooperative agreements pursuant to this section. | The BARDA shall be headed by a Director (referred to in this section as the “Director”) who shall be appointed by the Secretary and to whom the Secretary shall delegate such functions and authorities as necessary to implement this section, including the execution of procurement contracts, grants, and cooperative agreements pursuant to this section. | |||
| (4) | (4) Duties | (4) Duties |
§ 247d–7e(d)–(e)
(c)(4)(A)–(d) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (d)(1) | (1) Establishment | (1) Establishment | ||
| There is established the Biodefense Medical Countermeasure Development Fund, which shall be available to carry out this section in addition to such amounts as are otherwise available for this purpose. | There is established the Biodefense Medical Countermeasure Development Fund, which shall be available to carry out this section in addition to such amounts as are otherwise available for this purpose. | |||
| (d)(2) | (2) Funding | (2) Funding | ||
| To carry out the purposes of this section, there is authorized to be appropriated to the Fund $611,700,000 for each of fiscal years 2019 through 2023, such amounts to remain available until expended. | To carry out the purposes of this section, there is authorized to be appropriated to the Fund $611,700,000 for each of fiscal years 2019 through 2023, such amounts to remain available until expended. | |||
| (d)(3) | (3) [inserted: Pandemic influenza.—] | |||
| [inserted: To carry out this section and section 2811 with respect to pandemic influenza, in addition to amounts authorized to be appropriated by paragraph (2) and any amounts authorized to be appropriated by section 2811, there is authorized to be appropriated $335,000,000 for each of the fiscal years 2027 through 2031, to remain available until expended.] | ||||
| (e) | (e) Inapplicability of certain provisions | (e) Inapplicability of certain provisions | ||
| (e)(1) | (1) Disclosure | (1) Disclosure | ||
| (e)(1)(A) | (A) Nondisclosure of information | (A) Nondisclosure of information | ||
Rest of § 247d–7e unchanged
42 U.S.C. § 300hh–10 Coordination of preparedness for and response to all-hazards public health emergencies
5 changes the bill asks for here, 4 carried out
- Not carried out:
in paragraph (3), by inserting
, including the pandemic influenza medical countermeasures program under paragraphs (2)(E) and (4)(H) of section 319L(c)
afterqualified pandemic or epidemic products (as defined in section 319F–3)
; and“qualified pandemic or epidemic products (as defined in section 319F–3)” isn't in § 300hh–10(b)(3) in the Code as we have it. The law may have changed since the bill was drafted.
Technical detail
“qualified pandemic or epidemic products (as defined in section 319F–3)” not found in /us/usc/t42/s300hh–10/b/3 - Carried out:
in paragraph (7), by inserting
, including through the pandemic influenza medical countermeasures program under paragraphs (2)(E) and (4)(H) of section 319L(c)
afterfor each such threat
; and - Carried out:
in subparagraph (J), by striking
and
at the end; - Carried out:
by redesignating subparagraph (K) as subparagraph (L); and
- Carried out:
by inserting after subparagraph (J) the following:
(K) evaluate progress with respect to implementing the National Influenza Vaccine Modernization Strategy, issued in June 2020, or any successor strategy; and.
§ 300hh–10(b)Duties(6)–(7)
Start of § 300hh–10 to (b)(5) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (6) | (6) Leadership | (6) Leadership | ||
| Provide leadership in international programs, initiatives, and policies that deal with public health and medical emergency preparedness and response. | Provide leadership in international programs, initiatives, and policies that deal with public health and medical emergency preparedness and response. | |||
| (7) | (7) Countermeasures budget plan | (7) Countermeasures budget plan | ||
| Develop, and update not later than March 15 of each year, a coordinated 5-year budget plan based on the medical countermeasure priorities described in subsection (d), including with respect to chemical, biological, radiological, and nuclear agent or agents that may present a threat to the Nation, including such agents that are novel or emerging infectious diseases, and the corresponding efforts to develop qualified countermeasures (as defined in section 247d–6a of this title), security countermeasures (as defined in section 247d–6b of this title), and qualified pandemic or epidemic products (as defined in section 247d–6d of this title) for each such threat. Each such plan shall— | Develop, and update not later than March 15 of each year, a coordinated 5-year budget plan based on the medical countermeasure priorities described in subsection (d), including with respect to chemical, biological, radiological, and nuclear agent or agents that may present a threat to the Nation, including such agents that are novel or emerging infectious diseases, and the corresponding efforts to develop qualified countermeasures (as defined in section 247d–6a of this title), security countermeasures (as defined in section 247d–6b of this title), and qualified pandemic or epidemic products (as defined in section 247d–6d of this title) for each such threat[inserted: , including through the pandemic influenza medical countermeasures program under paragraphs (2)(E) and (4)(H) of section 319L(c)]. Each such plan shall— | |||
| (7)(A) | (A) | (A) | ||
| include consideration of the entire medical countermeasures enterprise, including— | include consideration of the entire medical countermeasures enterprise, including— | |||
| (7)(A)(i) | (i) | (i) | ||
| basic research and advanced research and development; | basic research and advanced research and development; |
§ 300hh–10(d)Public Health Emergency Medical Countermeasures Enterprise Strategy and Implementation Plan(2)–(3)
(b)(7)(A)(ii)–(d)(2)(J)(iii) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (2)(J)(iv) | (iv) | (iv) | ||
| whether, with respect to each procurement that is approved by the President under section 247d–6b(c)(6) of this title, a contract was entered into within one year after such approval by the President; and | whether, with respect to each procurement that is approved by the President under section 247d–6b(c)(6) of this title, a contract was entered into within one year after such approval by the President; and | |||
| (2)(J)(v) | (v) | (v) | ||
| with respect to section 247d–6a(d) of this title, for the 2-year period for which the report is submitted, the number of persons who were paid amounts totaling $100,000 or greater and the number of persons who were paid amounts totaling at least $50,000 but less than $100,000; | with respect to section 247d–6a(d) of this title, for the 2-year period for which the report is submitted, the number of persons who were paid amounts totaling $100,000 or greater and the number of persons who were paid amounts totaling at least $50,000 but less than $100,000; | |||
| (2)(K) | (K) [inserted: ] | |||
| [inserted: evaluate progress with respect to implementing the National Influenza Vaccine Modernization Strategy, issued in June 2020, or any successor strategy; and] | ||||
| (2)(L) | [inserted: (L)] | |||
| be made publicly available. | be made publicly available. | |||
| (3) | (3) GAO report | (3) GAO report | ||
| (3)(A) | (A) In general | (A) In general | ||
| Not later than 1 year after the date of the submission to the Congress of the first Public Health Emergency Medical Countermeasures Enterprise Strategy and Implementation Plan, the Comptroller General of the United States shall conduct an independent evaluation, and submit to the appropriate committees of Congress a report, concerning such Strategy and Implementation Plan. | Not later than 1 year after the date of the submission to the Congress of the first Public Health Emergency Medical Countermeasures Enterprise Strategy and Implementation Plan, the Comptroller General of the United States shall conduct an independent evaluation, and submit to the appropriate committees of Congress a report, concerning such Strategy and Implementation Plan. | |||
Rest of § 300hh–10 unchanged